| 초록 |
Patients with chronic kidney disease (CKD) should be educated on their condition, so that they can initiate dialysis at the optimal time and make an informed choice between dialysis modalities. Shared decision-making empowers patients to make decisions about their own treatment and improves patient outcomes. This study aims to evaluate whether shared decision-making affects the choice of renal replacement therapy among CKD patients. This is a multicenter, open-label, randomized, pragmatic clinical trial. A total of 1,194 participants with CKD considering renal replacement therapy were enrolled. The participants will be randomized into three groups in a 1:1:1 ratio: the conventional group, extensive informed decision-making group, and shared decision-making group. Participants will be educated twice at months 0 and 2. Videos and leaflets will be provided to all patients. Patients in the conventional group will receive 5 minutes of education each visit. The extensive informed decision-making group will receive more informed and detailed education using intensive learning materials for 10 min each time. Patients in the shared decision-making group will be educated for 10 min each time according to illness perception and items-based analysis. The primary endpoint is the ratio of hemodialysis to peritoneal dialysis and kidney transplantation among the groups. Secondary outcomes include events of unplanned dialysis, economic efficiency, patient satisfaction, patients' evaluation of the process, and patient adherence. The SDM-ART is an ongoing clinical study to investigate the effect of shared decision-making on the choice of renal replacement therapy in patients with CKD. |